During the treatment phase , there were no clinical signs observed that could be attributed to administration of COMPOUND_XXX , with the exception of injection site irritation which occurred in males at 0.6 mg / kg / day and females at doses ~ 0.2 mg / kg / day .
During the treatment phase , there were no clinical signs observed that could be attributed to administration of COMPOUND_XXX , with the exception of injection site irritation which occurred in males at 0.6 mg / kg / day and females at doses ~ 0.2 mg / kg / day .
O O O O O O O O O O O O O O O O O O O O O O O O B-FINDING I-FINDING I-FINDING O O O B-SEX O B-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE O B-SEX O O O B-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE O